The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122636435 12263643 5 F 20160907 20160413 20160913 PER PHEH2016US008953 NOVARTIS 0.00 M Y 106.58000 KG 20160913 CN COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122636435 12263643 1 PS EXTAVIA INTERFERON BETA-1B 1 Subcutaneous 0.0625 MG(0.25ML), QOD (WEEKS 1-2) 125290 .062 MG SOLUTION FOR INJECTION
122636435 12263643 2 SS EXTAVIA INTERFERON BETA-1B 1 Subcutaneous 0.125 MG(0.5ML), QOD (WEEKS 3-4) 125290 .125 MG SOLUTION FOR INJECTION
122636435 12263643 3 SS EXTAVIA INTERFERON BETA-1B 1 Subcutaneous 0.1875MG (0.75ML),QOD (WEEKS 5-6) 125290 .187 MG SOLUTION FOR INJECTION
122636435 12263643 4 SS EXTAVIA INTERFERON BETA-1B 1 Subcutaneous 0.25MG (1 ML),QOD (WEEKS 7+) 125290 .25 MG SOLUTION FOR INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122636435 12263643 1 Multiple sclerosis

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
122636435 12263643 Feeling hot
122636435 12263643 Injection site extravasation
122636435 12263643 Injection site nerve damage
122636435 12263643 Injection site pain
122636435 12263643 Paraesthesia
122636435 12263643 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122636435 12263643 1 20160406 0